CRL vs MRCC · rev $2.00B vs $110.1M cap
Charles River Laboratories (CRL) versus Monroe Capital Corp (MRCC) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Monroe Capital Corp (MRCC) is a asset management company listed on US.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
MRCC does not have a complete income-statement cache yet.
CRL currently screens at market cap $7.78B. MRCC currently screens at market cap $110.1M.
Not investment advice. Open the CRL and MRCC stock pages for the full models.
Not investment advice.